Czech Republic Pharma and Healthcare Sector Report 2018/2019

  • ID: 4462055
  • Report
  • Region: Czech Republic
  • 68 pages
  • EMIS, An ISI Emerging Markets Group Company
1 of 6
The Czech Republic's Total Healthcare Expenditures Amounted to CZK 338.4Bn in 2016, Accounting for 7.6% of GDP

FEATURED COMPANIES

  • Bioveta a.s.
  • FARMAK a.s.
  • HARTMANN-RICO a.s.
  • PRO.MED.CS Praha a.s.
  • VUAB Pharma a.s.
  • Zentiva k.s.
  • MORE
This report provides a complete and detailed analysis of the healthcare and pharmaceutical sector for the Czech Republic . The report presents in-depth business intelligence in a standard format across countries and regions, providing a balanced mix between analysis and data.

What this report allows you to do:
  • Understand the key elements at play in the healthcare and pharmaceutical sector in the Czech Republic
  • Access forecasts for growth in the sector
  • View key data on healthcare spending and health insurance in the Czech Republic
  • Crystallise the forces both driving and restraining this sector in the Czech Republic
  • Build a complete perspective on sector trade, investment and employment
  • Understand the competitive landscape and who the major players are
  • View M&A activity and major deals
  • Gain an understanding of the regulatory environment for the sector in the Czech Republic
  • Build a clear picture of trends and issues for sub-sectors (medical institutions, pharmaceuticals manufacturing and distribution channels).
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Bioveta a.s.
  • FARMAK a.s.
  • HARTMANN-RICO a.s.
  • PRO.MED.CS Praha a.s.
  • VUAB Pharma a.s.
  • Zentiva k.s.
  • MORE
1. EXECUTIVE SUMMARY
  • Sector Overview
  • Sector Snapshot
  • Sector Outlook
  • Subsector Outlook
  • Driving Forces
  • Restraining Forces
2. SECTOR IN FOCUS
  • Main Economic Indicators
  • Main Sector Indicators
  • Output and Gross Value Added
  • Pharmaceutical Production
  • Sales
  • Pharmaceutical Sales
  • New Orders
  • European Positioning
  • External Trade
  • Foreign Direct Investments
  • Employment and Wages
3. COMPETITIVE LANDSCAPE
  • Highlights
  • Top 20 Pharmaceutical Companies
  • Top M&A Deals
  • M&A Activity, 2015-H2 2017
4. COMPANIES IN FOCUS
  • Teva Pharmaceuticals CR s.r.o.
  • Zentiva k.s.
  • HARTMANN-RICO a.s.
  • PRO.MED.CS Praha a.s.
  • FARMAK a.s.
  • VUAB Pharma a.s.
  • Bioveta a.s.
5. REGULATORY ENVIRONMENT
  • Key Bodies
  • Government Policy VAT Rate
  • Investment Incentive
  • Health 2020: National Strategy
6. HEALTHCARE SERVICES
  • Highlights
  • Main Events
  • Healthcare Expenditures
  • Life Expectancy
  • Diseases Trends and Risk Factors
  • Number of Hospitals
  • Number of Beds in Hospitals
  • Employment
  • Medical Equipment
7. PRESCRIPTION DRUGS
  • Highlights
  • Sales
  • Patent and Generic Drugs
8. OVER-THE-COUNTER DRUGS
  • Highlights
  • Sales
  • Self-Medication Market
9. RETAIL CHANNELS
  • Retail
Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Bioveta a.s.
  • FARMAK a.s.
  • HARTMANN-RICO a.s.
  • PRO.MED.CS Praha a.s.
  • VUAB Pharma a.s.
  • Zentiva k.s.
  • MORE
The pharmaceutical sector in the Czech Republic generated a gross value added (GVA) of CZK 18.9bn in 2016, up by 8.2% y/y in real terms. It accounted for 0.44% of the total GVA in the economy in 2016. The sector employed 9,438 workers. Total healthcare expenditures amounted to CZK 338.4bn in 2016, accounting for 7.6% of GDP, according to OECD data. The healthcare expenditures increased by 3% y/y to CZK 338.4bn in 2016, mainly due to the higher contribution of public healthcare expenditures, which accounted for 83.4% of the total expenditures. The human health and social work activities employed 288,400 people in 2016, accounting for 7.3% of the total employment in the country.
Note: Product cover images may vary from those shown
5 of 6
  • Teva Pharmaceuticals CR s.r.o.
  • Zentiva k.s.
  • HARTMANN-RICO a.s.
  • PRO.MED.CS Praha a.s.
  • FARMAK a.s.
  • VUAB Pharma a.s.
  • Bioveta a.s.
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll